Skip to main content
Top
Published in: Diagnostic Pathology 1/2021

Open Access 01-12-2021 | Mastectomy | Case Report

Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review

Authors: Jing Lian, Li-Xia Wang, Jiang-hong Guo, Peng Bu, Yan-feng Xi, Ke-ming Yun

Published in: Diagnostic Pathology | Issue 1/2021

Login to get access

Abstract

Background

Secretory breast carcinoma is an uncommon subset of breast cancer that usually has a favorable outcome. Although initially described in children, it also occurs in adults where it may metastasize, possibly resulting in death. To date, only 20 cases of secretory breast carcinoma with distant metastases have been described.

Case presentation

A 42-year-old female presented with liver metastasis after modified radical mastectomy of the left breast in 2008 at 34 years of age. The liver metastasis was morphologically similar to the primary tumor. Pan-TRK and Fluorescence in situ hybridization showed a rearrangement in the ETV6 gene. She subsequently underwent adjuvant chemotherapy with a fatal outcome.

Conclusions

Although secretory breast carcinoma is usually associated with favorable outcomes, our study and reviews provide a novel insight into the genetic spectrum and treatment of secretory breast carcinoma showing reduced expression of hormone receptors, abnormal genomic profiles, and possible poor prognosis. Targeted therapy may curb clinically aggressive cases. Additional molecular investigations are needed to determine the links between specific mutations and poor prognosis.
Literature
1.
go back to reference Hoda RS, et al. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology. 2019;75(2):213–24.CrossRef Hoda RS, et al. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology. 2019;75(2):213–24.CrossRef
2.
go back to reference Jacob JD, et al. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol. 2016;113(7):721–5.CrossRef Jacob JD, et al. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol. 2016;113(7):721–5.CrossRef
3.
go back to reference Li L, et al. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16(1):139–46.CrossRef Li L, et al. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16(1):139–46.CrossRef
4.
go back to reference Tognon C, Huntsman SRK D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Poul HB, Sorensen. Expression of the ETV6–NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76. Tognon C, Huntsman SRK D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Poul HB, Sorensen. Expression of the ETV6–NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76.
5.
go back to reference Lae M, et al. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol. 2009;22(2):291–8.CrossRef Lae M, et al. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol. 2009;22(2):291–8.CrossRef
6.
go back to reference Herz H, Goldstein BCD. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol. 2000;11:1343–7.CrossRef Herz H, Goldstein BCD. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol. 2000;11:1343–7.CrossRef
7.
go back to reference Woto-Gaye G, et al. Secretory breast carcinoma in a man. A case report with rapid evolution unfavorable. Ann Pathol. 2004;24(5):432–5.CrossRef Woto-Gaye G, et al. Secretory breast carcinoma in a man. A case report with rapid evolution unfavorable. Ann Pathol. 2004;24(5):432–5.CrossRef
8.
go back to reference Ozguroglu M, et al. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68(2–3):263–8. Ozguroglu M, et al. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68(2–3):263–8.
9.
go back to reference Resetkova PACTAE. A large, fungating breast mass. Arch Pathol Lab Med. 2006;130:50–2.CrossRef Resetkova PACTAE. A large, fungating breast mass. Arch Pathol Lab Med. 2006;130:50–2.CrossRef
10.
go back to reference Wong M, et al. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 2012;18(6):604–6.CrossRef Wong M, et al. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 2012;18(6):604–6.CrossRef
11.
go back to reference Marie D, Castillo FdrC, Arnould L, Croce S, Ribeiro Agnes, Perot Gaëlle, Hostein Isabelle, Geha Sameh, Bozon Catherine, Garnier Agnes, Lae Marick, Vincent-Salomon Anne, MacGrogan Gaëtan. A histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol. 2015;39:1458–67.CrossRef Marie D, Castillo FdrC, Arnould L, Croce S, Ribeiro Agnes, Perot Gaëlle, Hostein Isabelle, Geha Sameh, Bozon Catherine, Garnier Agnes, Lae Marick, Vincent-Salomon Anne, MacGrogan Gaëtan. A histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol. 2015;39:1458–67.CrossRef
12.
go back to reference Neerav Shukla SSR, Mollah O, Baki, et al. Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma. JCO Precis Oncol; 2017;2017:PO.17.00034. Neerav Shukla SSR, Mollah O, Baki, et al. Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma. JCO Precis Oncol; 2017;2017:PO.17.00034.
13.
go back to reference Garlick JW, et al. Secretory breast carcinoma in an 8-year-old girl: a case report and literature review. Breast J. 2018;24(6):1055–61.CrossRef Garlick JW, et al. Secretory breast carcinoma in an 8-year-old girl: a case report and literature review. Breast J. 2018;24(6):1055–61.CrossRef
14.
go back to reference Landman Y, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapy-naive patients with advanced triple-negative secretory breast cancer expressing ETV6-NTRK3 fusion. Clin Breast Cancer. 2018;18(3):e267-70.CrossRef Landman Y, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapy-naive patients with advanced triple-negative secretory breast cancer expressing ETV6-NTRK3 fusion. Clin Breast Cancer. 2018;18(3):e267-70.CrossRef
15.
go back to reference Horowitz DP, et al. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21(3):350–3.CrossRef Horowitz DP, et al. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21(3):350–3.CrossRef
16.
go back to reference Jinhua Ding LJ, Gan Y, Wu W. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis. Int J Clin Exp Pathol. 2015;8:3322–7.PubMedPubMedCentral Jinhua Ding LJ, Gan Y, Wu W. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis. Int J Clin Exp Pathol. 2015;8:3322–7.PubMedPubMedCentral
17.
go back to reference Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;19(5):617–21.CrossRef Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;19(5):617–21.CrossRef
18.
go back to reference Osako T, et al. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis. Histopathology. 2013;63(4):509–19.PubMed Osako T, et al. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis. Histopathology. 2013;63(4):509–19.PubMed
19.
go back to reference Li D, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25(4):567–75.CrossRef Li D, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25(4):567–75.CrossRef
20.
go back to reference Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med. 2011;135(12):1606–10.CrossRef Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med. 2011;135(12):1606–10.CrossRef
21.
go back to reference Tavassoli FA, Norris HJ. Secretory carcinoma of the breast.Cancer. 1980;45:2404–13. Tavassoli FA, Norris HJ. Secretory carcinoma of the breast.Cancer. 1980;45:2404–13.
22.
go back to reference Tokunaga M, Wakimoto J, Muramoto Y, et al. Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol. 1985;15:457–65. Tokunaga M, Wakimoto J, Muramoto Y, et al. Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol. 1985;15:457–65.
23.
go back to reference Nguyen GK, Neifer R. Aspiration biopsy cytology of secretory carcinoma of the breast. Diagn Cytopathol. 1987;3:234–7. Nguyen GK, Neifer R. Aspiration biopsy cytology of secretory carcinoma of the breast. Diagn Cytopathol. 1987;3:234–7.
24.
go back to reference Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 1989;14:25–36. Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 1989;14:25–36.
25.
go back to reference Krohn M, Trams G, Brandt G. Secretory breast cancer. Secretory breast cancer. A special morphologic entity, especially in children and young females. Geburtshilfe Frauenheilkd. 1989;49:299–301. Krohn M, Trams G, Brandt G. Secretory breast cancer. Secretory breast cancer. A special morphologic entity, especially in children and young females. Geburtshilfe Frauenheilkd. 1989;49:299–301.
26.
go back to reference Arce C, Cortes-Padilla D, Huntsman DG, et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol. 2005;3:35. Arce C, Cortes-Padilla D, Huntsman DG, et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol. 2005;3:35.
27.
go back to reference Anderson P, Albarracin CT, Resetkova E. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med. 2006;130:e50–2. Anderson P, Albarracin CT, Resetkova E. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med. 2006;130:e50–2.
28.
go back to reference Landman Y, Ilouze M, Wein S, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapynaive patients with advanced triple-negative secretory breast cancer expressing ETV6–NTRK3 fusion. Clin Breast Cancer. 2018;18:e267–720. Landman Y, Ilouze M, Wein S, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapynaive patients with advanced triple-negative secretory breast cancer expressing ETV6–NTRK3 fusion. Clin Breast Cancer. 2018;18:e267–720.
Metadata
Title
Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review
Authors
Jing Lian
Li-Xia Wang
Jiang-hong Guo
Peng Bu
Yan-feng Xi
Ke-ming Yun
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2021
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-021-01156-6

Other articles of this Issue 1/2021

Diagnostic Pathology 1/2021 Go to the issue